Travere Therapeutics (TVTX) Shares Outstanding (Diluted) (2013 - 2026)

Travere Therapeutics (TVTX) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Travere Therapeutics 5.85 Bn 5.85 Bn 162.52 Mn 93.48 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 91.87 Mn
Mar 31, 2026 91.87 Mn
Dec 31, 2025 89.21 Mn
Sep 30, 2025 102.62 Mn
Jun 30, 2025 88.95 Mn
Mar 31, 2025 88.36 Mn
Dec 31, 2024 78.89 Mn
Sep 30, 2024 77.78 Mn
Jun 30, 2024 77.50 Mn
Mar 31, 2024 77.14 Mn
Dec 31, 2023 74.27 Mn
Sep 30, 2023 76.31 Mn
Jun 30, 2023 76.00 Mn
Mar 31, 2023 68.17 Mn
Dec 31, 2022 63.76 Mn
Sep 30, 2022 64.03 Mn
Jun 30, 2022 63.64 Mn
Mar 31, 2022 63.13 Mn
Dec 31, 2021 59.83 Mn
Sep 30, 2021 60.80 Mn